Delivery Order SPE2DB20D1051-SPE2DB24FD7FS
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has a total ceiling value of $2,521.04 and a period of performance through December 6, 2023. The contract is a firm-fixed-price type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF1BT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glimepiride 4 mg tablets, a pharmaceutical product used to treat diabetes. The contract has a ceiling value of $5,031.97 and an ultimate completion date of January 11, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp, a...
- This federal contract award, valued at $3,366.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 13, 2024 and is a firm fixed-price delivery order. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,979.81 firm fixed-price delivery order covers the procurement of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2020. This award is associated with Amerisourcebergen's $999,999,999 Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $1,711.76 and a completion date of June 18, 2025. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $2,043.05 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,247.78 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
- This federal contract award, valued at $5,760.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This federal contract award is for the delivery of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The $1,168.10 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 25, 2024. The contract has an ultimate completion date of October 28, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $3,905.92 and a period of performance through March 7, 2024. This is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...